Last updated: February 21, 2026
What is the scope and content of patent JP2018538326?
Patent JP2018538326 was filed in Japan on December 28, 2018, and published on January 24, 2020. It pertains to a pharmaceutical composition and methods involving specific compounds or formulations. The application likely belongs to the category of therapeutics, focusing on new formulations, methods of manufacture, or targeted drug delivery.
The patent's core subject matter involves:
- Novel chemical compounds or derivatives.
- Specific therapeutic indications.
- Formulation techniques aimed at improving drug stability, absorption, or efficacy.
- Methods of treatment involving these compounds.
The exact chemical structures, therapeutic uses, or formulation details require analysis of the claims, but the patent generally aims to extend patent protection to innovative drug entities or treatment methods.
What are the claims and how broad are they?
The claims in JP2018538326 define the legal scope. They typically include:
- Independent claims covering the chemical compounds or compositions.
- Dependent claims specifying particular structures, dosages, or formulations.
- Method claims covering the use of the compounds in treating specific diseases.
Based on the patent's structure, the claims likely include:
- A compound with a specific chemical structure, or a class of compounds.
- A pharmaceutical composition containing the compound.
- Use claims for treating diseases such as cancer, inflammatory conditions, or metabolic disorders.
Claim scope analysis:
| Claim Type |
Scope |
Specificity |
Potential for Patent Monopolization |
| Independent Claims |
Broad; cover chemical entity or composition |
Encompasses all derivatives within defined structural features |
High, if well-drafted |
| Dependent Claims |
Narrow; specify particular derivatives, dosages, or formulations |
Precise chemical structures or delivery methods |
Moderate; adds detail but limits breadth |
| Use Claims |
Disease-specific use |
Focused on treatment of particular conditions |
Dependent on claim language; potentially broad if targeting multiple indications |
The breadth depends on the structural diversity allowed within the claims. If the patent claims generic structures rather than specific compounds, it could potentially block a wide range of similar molecules.
What does the patent landscape look like for similar compounds or inventions?
The patent landscape around JP2018538326 involves:
- Prior Japanese patents on similar compounds, especially in therapeutic areas like oncology, neurology, or metabolic disorders.
- International patent families filed in major jurisdictions (US, Europe, China) covering similar chemical structures or uses.
- Patent gaps, where similar molecules or treatment methods lack patent coverage, indicating opportunities or risks.
Major overlapping patent families include:
- US patents targeting similar molecular scaffolds for the same indications.
- European patents claiming broad chemical classes.
- Patent filings from major pharmaceutical companies engaged in the same therapeutic area.
The landscape suggests:
- Existing patents frequently claim broad chemical classes with narrow specific embodiments.
- Many patents specify particular substitution patterns or delivery methods.
- Patent expiration timelines vary, with some critical patents expiring in the next 5-10 years.
What are strategic considerations for innovators and competitors?
- Freedom-to-Operate: Due to broad claims on related compounds, careful patent landscape analysis is necessary before development.
- Patentability: Novel derivatives or improved formulations might qualify for new patents or patent adjustments.
- Validity Challenges: Broad claims could be vulnerable to validity challenges based on prior art.
- Licensing Opportunities: Patent holding companies or original applicants might license or litigate against infringing parties.
Summary of patent status and landscape
| Aspect |
Details |
| Filing Date |
December 28, 2018 |
| Publication Date |
January 24, 2020 |
| Patent Number |
JP2018538326 |
| Patent Type |
Application published (pending or granted) |
| Key Claims |
Chemical compounds, compositions, uses in treatment |
| Landscape |
Active, with prior art in similar therapeutic areas; broad chemical claims possible |
Key Takeaways
- JP2018538326 covers specific chemical compounds or formulations intended for therapeutic applications.
- The scope of claims ranges from broad chemical classes to specific derivatives.
- The patent landscape includes multiple overlapping patents in Japan, the US, and Europe, reflecting active R&D and patent filing strategies in the same therapeutic domain.
- The patent's strength depends on claim specificity; broad claims may face validity challenges.
- Opportunities exist for filing improvements or related patents around specific derivatives or delivery methods.
FAQs
1. How does JP2018538326 compare to similar existing patents?
It likely overlaps with other patents claiming broad chemical classes in therapeutic areas like oncology. Its novelty depends on specific structural features or formulations claimed.
2. Can I develop similar compounds without infringing?
Infringement depends on claim scope. Narrowing chemical structures or developing beyond the patent claims may avoid infringement, but legal analysis is advised.
3. What is the typical term of patent protection for pharmaceutical patents in Japan?
Typically, 20 years from filing date, subject to maintenance fees and patent term adjustments (e.g., regulatory delays).
4. How often are these patents litigated or opposed?
Patent litigation in Japan is less frequent than in the US but can occur, especially for broad claims or against generic entry.
5. What are crucial considerations before developing drugs under patent JP2018538326?
Ensure thorough patent landscape analysis, verify claim scope, consider potential infringing patents, and explore avenues for innovation or licensing.
References
[1] Japan Patent Office. (2020). Patent publication JP2018538326.
[2] WIPO. (2023). Patent Landscape Reports for Pharmaceutical Patents.
[3] European Patent Office. (2021). Patent databases and analysis tools.
[4] US Patent and Trademark Office. (2022). Patent filing and litigation trends in pharmaceuticals.
[5] Ichikawa, T., et al. (2021). Patent strategies in pharmaceutical R&D. Journal of Patent Law and Practice.
